NCT06785675 - Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

November 29, 2025

Study Completion Date

November 29, 2025

Conditions

Hidradenitis Suppurativa

Interventions

OTHER

Secukinumab

This is an observational study. There is no treatment allocation.

Trial Locations (4)

RECRUITING

Novartis Investigative Site, Al Ain Abu Dhabi

RECRUITING

Novartis Investigative Site, Abu Dhabi

RECRUITING

Novartis Investigative Site, Ras al-Khaimah

RECRUITING

Novartis Investigative Site, Sharjah city